Literature DB >> 3219363

CP4: a pneumocyte-derived collagenous surfactant-associated protein. Evidence for heterogeneity of collagenous surfactant proteins.

A Persson1, K Rust, D Chang, M Moxley, W Longmore, E Crouch.   

Abstract

Type II pneumocytes secrete pulmonary surfactant and are known to synthesize SP-35, a collagenous surfactant-associated protein. Freshly isolated type II cells also synthesize other bacterial collagenase-sensitive and hydroxyproline-containing proteins, including a glycoprotein designated CP4. CP4 was isolated from rat pneumocyte culture medium by immune precipitation with polyclonal antibodies to rat surfactant proteins or by DEAE chromatography and reverse-phase or gel permeation HPLC. CP4 did not cross-react with polyclonal antibodies to SP-35 and was completely resolved from SP-35 by SDS-PAGE (Mr 43K reduced) or isoelectric focusing. Unlike SP-35, which consists of acidic isoforms assembled as disulfide-bonded dimers and multimers, CP4 was secreted as basic isoforms assembled as disulfide-bonded trimers. Differences in primary structure were demonstrated by CNBr and V8 protease peptide mapping. The secretion of both proteins was inhibited by 2,2'-dipyridyl, an inhibitor of posttranslational prolyl and lysyl hydroxylation and collagen triple helix formation. CP4 was isolated from EDTA extracts of rat surfactant. These studies provide evidence for the heterogeneity of pneumocyte-derived collagenous surfactant-associated proteins.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3219363     DOI: 10.1021/bi00423a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  20 in total

Review 1.  Function and regulation of expression of pulmonary surfactant-associated proteins.

Authors:  T E Weaver; J A Whitsett
Journal:  Biochem J       Date:  1991-01-15       Impact factor: 3.857

Review 2.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

3.  Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.

Authors:  S F Kuan; K Rust; E Crouch
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

4.  Surfactant protein D binding to alveolar macrophages.

Authors:  K Miyamura; L E Leigh; J Lu; J Hopkin; A López Bernal; K B Reid
Journal:  Biochem J       Date:  1994-05-15       Impact factor: 3.857

5.  Surfactant protein D (SP-D) counteracts the inhibitory effect of surfactant protein A (SP-A) on phospholipid secretion by alveolar type II cells. Interaction of native SP-D with SP-A.

Authors:  Y Kuroki; M Shiratori; Y Murata; T Akino
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

6.  Purification, characterization and cDNA cloning of human lung surfactant protein D.

Authors:  J Lu; A C Willis; K B Reid
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

7.  Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis.

Authors:  E Crouch; A Persson; D Chang; D Parghi
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

8.  Structural similarity between bovine conglutinin and bovine lung surfactant protein D and demonstration of liver as a site of synthesis of conglutinin.

Authors:  B L Lim; J Lu; K B Reid
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

9.  Rat surfactant protein D enhances the production of oxygen radicals by rat alveolar macrophages.

Authors:  J F Van Iwaarden; H Shimizu; P H Van Golde; D R Voelker; L M Van Golde
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

10.  The pulmonary surfactant: impact of tobacco smoke and related compounds on surfactant and lung development.

Authors:  J Elliott Scott
Journal:  Tob Induc Dis       Date:  2004-03-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.